Republic Financial Corporation
Home
About Republic
  • About Us
  • Executives
Our Companies
  • Aviation
  • CeDUR
  • HepQuant
  • RFC Drilling
  • Special Situations
  • Tinuum
Republic Financial Corporation
Home
About Republic
  • About Us
  • Executives
Our Companies
  • Aviation
  • CeDUR
  • HepQuant
  • RFC Drilling
  • Special Situations
  • Tinuum
More
  • Home
  • About Republic
    • About Us
    • Executives
  • Our Companies
    • Aviation
    • CeDUR
    • HepQuant
    • RFC Drilling
    • Special Situations
    • Tinuum
  • Home
  • About Republic
    • About Us
    • Executives
  • Our Companies
    • Aviation
    • CeDUR
    • HepQuant
    • RFC Drilling
    • Special Situations
    • Tinuum

 HepQuant is a privately-held, early-stage medical diagnostics company with unique, patented and patent-pending technology for evaluating liver function in patients with liver disease.  The liver is the only major organ that does not have a proven function test. Once approved, HepQuant will fill this void.  

  

Through its Investigational Device Exemption (IDE), HepQuant provides liver testing support services to liver research centers and pharmaceutical companies. The HepQuant tests are designed to evaluate the liver — and levels of hepatic impairment — regardless of the origins of the liver disease. Specifically, the tests establish a Disease Severity Index (DSI) score by measuring hepatic blood flow, portal blood flow, and portal-systemic shunt in patients suffering from chronic liver disease (CLD). HepQuant is currently filing for its FDA approval.

Location: Denver, Colorado

Founded: 2007

hepquant.com

Copyright © 2022 Republic Financial Corporation - All Rights Reserved.

Powered by GoDaddy

  • Privacy Policy
  • Terms of Use
  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept